Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis
申请人:Warner-Lambert Company
公开号:US06239288B1
公开(公告)日:2001-05-29
Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of bums, decubital ulcers, wound healing, cancer, inflammation, pain, arthritis, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes or other activated migrating cells, acute and chronic neurodegenerative disorders including stroke, head trauma, spinal cord injury, Alzheimer's disease, amyotrophic lateral sclerosis, cerebral amyloid angiopathy, AIDS, Parkinson's disease, Huntington's disease, prion diseases, myasthenia gravis, and Duchenne's muscular dystrophy.
本文描述了联苯基丁酸化合物及其衍生物,以及制备该化合物的酸方法和制药组合物,该化合物可用作基质金属蛋白酶抑制剂,特别是明胶酶A(72 kD明胶酶)和stromelysin-1的抑制剂,用于治疗多发性硬化症、动脉粥样硬化斑块破裂、主动脉瘤、心力衰竭、再狭窄、牙周病、角膜溃疡、烧伤、褥疮、伤口愈合、癌症、炎症、关节炎或其他依赖于白细胞或其他激活迁移细胞侵袭组织的自身免疫或炎症性疾病,以及急性和慢性神经退行性疾病,包括中风、头部创伤、脊髓损伤、阿尔茨海默病、肌萎缩性侧索硬化、脑淀粉样血管病、艾滋病、帕金森病、亨廷顿病、朊病、重症肌无力和杜兴氏肌萎缩症。